Lifeward (LFWD) Projected to Post Earnings on Friday

Lifeward (NASDAQ:LFWD) is anticipated to post its Q3 2026 results before the market opens on Friday, November 13th. Analysts expect Lifeward to post earnings of ($0.7850) per share and revenue of $7.24 million for the quarter. Parties may review the information on the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Friday, November 20, 2026 at 8:30 AM ET.

Lifeward (NASDAQ:LFWD) last released its quarterly earnings results on Saturday, August 15th. The company reported ($1.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.39) by ($0.07). The business had revenue of $6.62 million for the quarter, compared to analysts’ expectations of $6.53 million. Lifeward had a negative return on equity of 235.86% and a negative net margin of 141.28%. On average, analysts expect Lifeward to post ($0.44) EPS for the current fiscal year and ($1.84) EPS for the next fiscal year.

Lifeward Stock Down 0.9%

Shares of NASDAQ:LFWD opened at $5.88 on Wednesday. The business has a 50-day moving average price of $6.48 and a 200 day moving average price of $6.89. The company has a current ratio of 2.33, a quick ratio of 1.77 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $16.67 million, a price-to-earnings ratio of -0.35 and a beta of 0.55. Lifeward has a 12-month low of $4.14 and a 12-month high of $9.61.

Analysts Set New Price Targets

LFWD has been the topic of a number of recent analyst reports. HC Wainwright reaffirmed a “buy” rating and issued a $10.00 target price on shares of Lifeward in a research report on Friday, August 21st. Zacks Research upgraded shares of Lifeward from a “strong sell” rating to a “hold” rating in a research report on Monday, July 27th. Citigroup reissued a “buy” rating on shares of Lifeward in a research note on Friday, August 21st. Finally, Weiss Ratings raised shares of Lifeward from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, October 9th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Lifeward presently has an average rating of “Hold” and an average target price of $10.00.

About Lifeward

Lifeward Ltd. (NASDAQ: LFWD) is a medical technology company focused on developing and commercializing wearable robotic systems designed to help people with mobility impairments stand, walk and participate in rehabilitation. The company was formerly known as ReWalk Robotics and adopted the Lifeward name in 2024. Lifeward’s principal product line is the ReWalk Personal Exoskeleton, a battery-powered wearable robotic device intended to enable individuals with lower-limb disabilities, including those resulting from spinal cord injury, to walk with the assistance of crutches or other support.